Display options
Cite
Yun KW, Lee MK, Kim W, et al. Uropathogenic . Korean J Pediatr. 2017;60(7):221-226doi: 10.3345/kjp.2017.60.7.221.
Yun, K. W., Lee, M. K., Kim, W., & Lim, I. S. (2017). Uropathogenic . Korean journal of pediatrics, 60(7), 221-226. https://doi.org/10.3345/kjp.2017.60.7.221
Yun, Ki Wook, et al. "Uropathogenic ." Korean journal of pediatrics vol. 60,7 (2017): 221-226. doi: https://doi.org/10.3345/kjp.2017.60.7.221
Yun KW, Lee MK, Kim W, Lim IS. Uropathogenic . Korean J Pediatr. 2017 Jul;60(7):221-226. doi: 10.3345/kjp.2017.60.7.221. Epub 2017 Jul 31. PMID: 28861113; PMCID: PMC5573745.
Copy Download .nbib Format: NLM
Share it on

Korean J Pediatr. 2017 Jul;60(7):221-226. doi: 10.3345/kjp.2017.60.7.221. Epub 2017 Jul 31.

Uropathogenic .

Korean journal of pediatrics

Ki Wook Yun, Mi-Kyung Lee, Wonyong Kim, In Seok Lim

Affiliations

  1. Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea.
  2. Department of Laboratory Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
  3. Department of Microbiology, Chung-Ang University College of Medicine, Seoul, Korea.
  4. Department of Pediatrics, Chung-Ang University College of Medicine, Seoul, Korea.

PMID: 28861113 PMCID: PMC5573745 DOI: 10.3345/kjp.2017.60.7.221

Abstract

METHODS: We examined 114 uropathogenic

RESULTS: Sixteen UPEC isolates (14.0%) were extended-spectrum β-lactamase (ESBL)-producers; 50.0% of ESBL-producers were ST131 isolates. Of all the isolates tested, 13.2% (15 of 114) were classified as ST131. There were no statistically significant associations between ST131 and age, sex, or clinical characteristics, including fever, white blood cell counts in urine and serum, C-reactive protein, radiologic abnormalities, and clinical outcome. However, ST131 isolates showed significantly lower rates of susceptibility to cefazolin (26.7%), cefotaxime (40.0%), cefepime (40.0%), and ciprofloxacin (53.3%) than non-ST131 isolates (65.7%, 91.9%, 92.9%, and 87.9%, respectively;

CONCLUSION: ST131

Keywords: Child; Escherichia coli; Multilocus sequence typing; Urinary tract infection

Conflict of interest statement

Conflict of interest: No potential conflict of interest relevant to this article was reported.

References

  1. Clin Infect Dis. 2008 Mar 1;46(5):689-95 - PubMed
  2. J Korean Med Sci. 2013 Jul;28(7):998-1004 - PubMed
  3. Curr Opin Microbiol. 2006 Oct;9(5):466-75 - PubMed
  4. Pediatr Infect Dis J. 2015 May;34(5):469-75 - PubMed
  5. N Engl J Med. 2011 Jul 21;365(3):239-50 - PubMed
  6. Clin Infect Dis. 2015 Feb 15;60(4):523-7 - PubMed
  7. Clin Infect Dis. 2013 Nov;57(9):1256-65 - PubMed
  8. Appl Environ Microbiol. 2000 Oct;66(10):4555-8 - PubMed
  9. Diagn Microbiol Infect Dis. 2015 Jan;81(1):44-6 - PubMed
  10. Korean J Pediatr. 2015 Jan;58(1):20-7 - PubMed
  11. Korean J Pediatr. 2012 Nov;55(11):420-3 - PubMed
  12. J Clin Microbiol. 2005 Dec;43(12):5860-4 - PubMed
  13. Diagn Microbiol Infect Dis. 2012 Mar;72(3):248-52 - PubMed
  14. J Bacteriol. 2004 Mar;186(5):1518-30 - PubMed
  15. Pediatr Int. 2016 Jun;58(6):467-71 - PubMed
  16. Clin Infect Dis. 2010 Aug 1;51(3):286-94 - PubMed
  17. Clin Infect Dis. 2015 May 1;60(9):1389-97 - PubMed
  18. J Antimicrob Chemother. 2011 Jan;66(1):1-14 - PubMed
  19. Pediatr Int. 2012 Dec;54(6):858-62 - PubMed
  20. Microb Drug Resist. 2015 Aug;21(4):463-9 - PubMed
  21. BMC Infect Dis. 2012 Jun 29;12:149 - PubMed
  22. Infect Chemother. 2013 Dec;45(4):415-21 - PubMed

Publication Types